• Je něco špatně v tomto záznamu ?

Glycated α-Synuclein Renders Glial Cell Activation and Induces Degeneration of Dopaminergic Neurons: A Potential Implication for the Development of Parkinson's Disease

S. Chatterjee, A. Verma, H. Thakkar, RP. Shah, A. Khairnar

. 2025 ; 20 (3) : 632-645. [pub] 20250221

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc25009451

Accumulation of misfolded α-synuclein (α-Syn) leads to the formation of Lewy bodies and is a major hallmark of Parkinson's disease (PD). The accumulation of α-Syn involves several post-translational modifications. Recently, though, glycation of α-Syn (advanced glycation end products) and activation of the receptor for advanced glycation end products (RAGE) have been linked to neuroinflammation, which leads to oxidative stress and accumulation of α-Syn. The present study aims to detect the effect of glycated α-Syn (gly-α-Syn)-induced synucleinopathy and loss of dopaminergic (DAergic) neurons in the development of PD. We isolated, purified, and prepared glycated recombinant human α-Syn using d-ribose. Gly-α-Syn was characterized by SDS-PAGE, intact mass analysis, and bottom-up peptide sequence through LC-HRMS/MS. The aggregation propensity of gly-α-Syn has been verified by morphological and shape analysis through Bio-AFM. The gly-α-Syn (2 μg/μL) was injected stereotaxically in the substantia nigra (SN) of ICR mice (3-4 months) and compared with the normal α-Syn, d ribose, and Tris-HCl/artificial CSF groups. 56 days postsurgery (DPS), an immunohistochemical examination was conducted to investigate gly-α-Syn-induced α-Syn accumulation, neuroinflammation, and neurodegeneration. The glycation of α-Syn led to the expression of transglutaminase 2 (TGM2), an enzyme that cross-linked with AGEs and may have caused the accumulation of α-Syn. Significant RAGE activation was also observed in gly-α-Syn, which might have induced glial cell activation, resulting in oxidative stress and, ultimately, apoptosis of dopaminergic neurons. It is important to note that TGM2, phosphorylated α-Syn, RAGE expression, and glial cell activation were only found in the gly-α-Syn group and not in the other groups. This suggests that gly-α-Syn plays a major role in synucleinopathy, neuroinflammation, and neurodegeneration. Overall, the present study demonstrated glycation of α-Syn as one of the important age-associated post-translational modifications that are involved in the degeneration of dopaminergic neurons, at least in a subset of the diabetic patients susceptible to developing PD.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25009451
003      
CZ-PrNML
005      
20250429135227.0
007      
ta
008      
250415s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1021/acschembio.4c00777 $2 doi
035    __
$a (PubMed)39982250
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Chatterjee, Sayan $u Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), Ahmedabad, Gujarat 382355, India
245    10
$a Glycated α-Synuclein Renders Glial Cell Activation and Induces Degeneration of Dopaminergic Neurons: A Potential Implication for the Development of Parkinson's Disease / $c S. Chatterjee, A. Verma, H. Thakkar, RP. Shah, A. Khairnar
520    9_
$a Accumulation of misfolded α-synuclein (α-Syn) leads to the formation of Lewy bodies and is a major hallmark of Parkinson's disease (PD). The accumulation of α-Syn involves several post-translational modifications. Recently, though, glycation of α-Syn (advanced glycation end products) and activation of the receptor for advanced glycation end products (RAGE) have been linked to neuroinflammation, which leads to oxidative stress and accumulation of α-Syn. The present study aims to detect the effect of glycated α-Syn (gly-α-Syn)-induced synucleinopathy and loss of dopaminergic (DAergic) neurons in the development of PD. We isolated, purified, and prepared glycated recombinant human α-Syn using d-ribose. Gly-α-Syn was characterized by SDS-PAGE, intact mass analysis, and bottom-up peptide sequence through LC-HRMS/MS. The aggregation propensity of gly-α-Syn has been verified by morphological and shape analysis through Bio-AFM. The gly-α-Syn (2 μg/μL) was injected stereotaxically in the substantia nigra (SN) of ICR mice (3-4 months) and compared with the normal α-Syn, d ribose, and Tris-HCl/artificial CSF groups. 56 days postsurgery (DPS), an immunohistochemical examination was conducted to investigate gly-α-Syn-induced α-Syn accumulation, neuroinflammation, and neurodegeneration. The glycation of α-Syn led to the expression of transglutaminase 2 (TGM2), an enzyme that cross-linked with AGEs and may have caused the accumulation of α-Syn. Significant RAGE activation was also observed in gly-α-Syn, which might have induced glial cell activation, resulting in oxidative stress and, ultimately, apoptosis of dopaminergic neurons. It is important to note that TGM2, phosphorylated α-Syn, RAGE expression, and glial cell activation were only found in the gly-α-Syn group and not in the other groups. This suggests that gly-α-Syn plays a major role in synucleinopathy, neuroinflammation, and neurodegeneration. Overall, the present study demonstrated glycation of α-Syn as one of the important age-associated post-translational modifications that are involved in the degeneration of dopaminergic neurons, at least in a subset of the diabetic patients susceptible to developing PD.
650    12
$a alfa-synuklein $x metabolismus $7 D051844
650    _2
$a zvířata $7 D000818
650    12
$a dopaminergní neurony $x metabolismus $x patologie $x účinky léků $7 D059290
650    12
$a Parkinsonova nemoc $x metabolismus $x patologie $7 D010300
650    _2
$a lidé $7 D006801
650    _2
$a myši $7 D051379
650    12
$a neuroglie $x metabolismus $x patologie $x účinky léků $7 D009457
650    _2
$a myši inbrední ICR $7 D008813
650    _2
$a glykosylace $7 D006031
650    _2
$a produkty pokročilé glykace $x metabolismus $7 D017127
650    _2
$a substantia nigra $x metabolismus $x patologie $7 D013378
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a oxidační stres $7 D018384
650    _2
$a receptor pro konečné produkty pokročilé glykace $x metabolismus $7 D000067759
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Verma, Arvind $u Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), Ahmedabad, Gujarat 382355, India
700    1_
$a Thakkar, Harsh $u Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), Ahmedabad, Gujarat 382355, India $1 https://orcid.org/0000000238427603
700    1_
$a Shah, Ravi P $u Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), Ahmedabad, Gujarat 382355, India $1 https://orcid.org/0000000272386630
700    1_
$a Khairnar, Amit $u Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), Ahmedabad, Gujarat 382355, India $u International Clinical Research Centre, St. Anne's University Hospital Brno, Brno 60200, Czech Republic $u ICRC, FNUSA, Brno 65691, Czech Republic $u Department of Physiology, Faculty of Medicine, Masaryk University, Brno 62500, Czech Republic $u International Clinical Research Centre, Faculty of Medicine, Masaryk University, Brno 62500, Czech Republic $1 https://orcid.org/000000033375774X
773    0_
$w MED00179502 $t ACS chemical biology $x 1554-8937 $g Roč. 20, č. 3 (2025), s. 632-645
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39982250 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429135223 $b ABA008
999    __
$a ok $b bmc $g 2311064 $s 1246532
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 20 $c 3 $d 632-645 $e 20250221 $i 1554-8937 $m ACS chemical biology $n ACS Chem Biol $x MED00179502
LZP    __
$a Pubmed-20250415

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...